10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q 

(Mark one) 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2023

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ____________ to __________

Commission File Number: 333-180954 

HAWKEYE SYSTEMS, INC. 

(Exact name of registrant as specified in its charter) 

Nevada	83-0799093
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer  Identification No.)

6605 Abercorn, Suite 204

Savannah, GA 31405

(Address of principal executive offices (Zip Code) 

(912) 253-0375 

Registrant’s telephone number, including area code  

____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act

Title of Each Class	Trading  Symbol(s)	Name of each Exchange  on which registered
N/A	N/A	N/A

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes     ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Non-accelerated Filer	☒
Accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes     ☐ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

The number of shares outstanding of each of the issuer’s classes of common equity as of February 8, 2024, was 5,552,222 shares of common stock.

TABLE OF CONTENTS

		Page
Part 1	FINANCIAL INFORMATION	3
Item 1	Financial Statements (unaudited)	3
	Condensed Consolidated Balance Sheets as of December 31, 2023 (unaudited) and June 30, 2023 (audited)	3
	Condensed Consolidated Statements of Operations for the three months and six months ended December 31, 2023 and 2022 (unaudited)	4
	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months and six months ended December 31, 2023 and 2022 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2023 and 2022 (unaudited)	6
	Notes to the Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 4.	Controls and Procedures	16
Part II.	OTHER INFORMATION	17
Item 1	Legal Proceedings	17
Item 1A	Risk Factors	17
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	17
Item 3	Defaults Upon Senior Securities	17
Item 4	Mine Safety Disclosures	17
Item 5	Other Information	17
Item 6	Exhibits	18
	SIGNATURES	19

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	(Unaudited) December 31,			(Audited) June 30,
	2023			2023
ASSETS
Current assets:
Cash	$	398		$	143,861
Prepaid expenses		10,000			2,370
Interest receivable		116,893			40,438
Loan receivable		1,548,000			800,000
Total current assets		1,675,291			986,669
Total assets	$	1,675,291		$	986,669
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities – related party	$	383,718		$	730,454
Accounts payable and accrued liabilities		15,580			13,644
Convertible note payable, net of discount - related party		500,000			500,000
Accrued interest – related party		491,802			298,158
Line of credit – related party		525,000			525,000
Promissory note payable – related party		1,729,750			1,000,000
Total current liabilities		3,645,850			3,067,256
Long-term liabilities:
Loan payable due to Eagle - JV partner		442,251			442,251
Total liabilities		4,088,101			3,509,507
Commitments and contingencies (Note -13)		-			-
Stockholders’ deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 5,552,222 and 5,552,222 shares issued and outstanding, respectively		555			555
Common shares to be Issued		497,528			-
Additional paid-in capital		9,585,094			9,585,094
Accumulated deficit		(12,495,987	)		(12,108,487	)
Total stockholders’ deficit		(2,412,810	)		(2,522,838	)
Total liabilities and stockholders’ deficit	$	1,675,291		$	986,669

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						Six Months Ended
	December 31,						December 31,
	2023			2022			2023			2022
Operating expenses:
General and administrative	$	16,170		$	21,212		$	37,765		$	48,966
Management compensation		78,167			111,250			189,417			222,551
Professional fees		37,133			86,865			73,129			107,291
Professional fees - related party		-			-			-			15,000
Total operating expenses		131,470			219,327		$	300,311		$	393,808
Loss from operations		(131,470	)		(219,327	)	$	(300,311	)	$	(393,808	)
Other income (expense), net:
Other income		15,000			-			30,000			-
Interest income		44,450			-			76,454			-
Interest expense - related party		(101,234	)		(46,965	)		(193,644	)		(87,580	)
Total other income (expense), net		(41,784	)		(46,965	)		(87,190	)		(87,580	)
Net loss before income taxes provision		(173,254	)		(266,292	)		(387,501	)	$	(481,388	)
Provision for income tax		-			-			-			-
Net loss	$	(173,254	)	$	(266,292	)	$	(387,501	)	$	(481,388	)
Net loss per common share - basic and diluted	$	(0.03	)	$	(0.10	)	$	(0.07	)	$	(0.10	)
Weighted average common shares outstanding - basic and diluted		5,552,222			4,227,082			5,552,222			3,982,582

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

For the Six Months ended December 31, 2023

					Additional		Stock
	Common Stock				Paid-in		To Be		Accumulated
	Shares		Amount		Capital		Issued		Deficit			Total
Balance, June 30, 2023		5,552,223	$	555	$	9,585,094	$	-	$	(12,108,487	)	$	(2,522,838	)
Net loss								-		(214,247	)		(214,247	)
Balance, September 30, 2023		5,552,223	$	555	$	9,585,094	$	-	$	(12,322,734	)	$	(2,737,085	)
Common stock issued for settlement of compensation		-		-		-		497,528		-			497,528
Net loss		-		-		-		-		(173,254	)		(173,254	)
Balance, December 31, 2023		5,552,223	$	555	$	9,585,094	$	497,528	$	(12,495,987	)	$	(2,412,810	)

For the Six Months ended December 31, 2022

					Additional
	Common Stock				Paid-in		Accumulated
	Shares		Amount		Capital		Deficit			Total
Balance, June 30, 2022		2,560,416	$	256	$	8,778,391	$	(10,882,176	)	$	(2,103,529	)
Common stock issued for common stock payable		1,666,667		167		594,177		-			594,344
Stock based compensation – options		-		-		5,159		-			5,159
Net loss								(215,096	)		(215,096	)
Balance, September 30, 2022		4,227,083	$	423	$	9,377,727	$	(11,097,272	)	$	(1,719,122	)
Net loss		-		-		-		(266,292	)		(266,292	)
Balance, December 31, 2022		4,227,083	$	423	$	9,377,727	$	(11,363,564	)	$	(1,985,414	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Six Months Ended
	December 31,
	2023			2022
Cash flows from operating activities:
Net loss	$	(387,501	)	$	(481,388	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation – options and warrant		-			5,159
Common stock issued for settlement of compensation		497,528			-
Change in operating assets and liabilities:
Prepaid expense		(7,631	)		(8,147	)
Interest receivable		(76,455	)		-
Accounts payable and accrued liabilities– related party		(346,735	)		284,083
Accounts payable and accrued liabilities		1,936			-
Accrued interest - related party		193,644			-
Net cash used in operating activities		(125,213	)		(200,293	)
Cash flows from investing activities:
Note receivable from CNTNR		(748,000	)		-
Net cash used in investing activities		(748,000	)		-
Cash flows from financing activities:
Net proceeds from Promissory note - related party		729,750			-
Net proceeds from line of credit		-			200,000
Net cash provided by financing activities		729,750			200,000
Net change in cash		(143,463	)		(293	)
Cash beginning of period		143,861			325
Cash end of period	$	398		$	32
Supplemental cash flow information
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-cash investing and financing activities:
Common stock issued exchanged for common stock payable – related party	$	-		$	594,344
Common stock to be issued for settlement of service	$	497,528		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

6

HAWKEYE SYSTEMS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2023

Note 1 - Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources.

Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

As of December 31, 2023, and 2022, the Company had no revenue.

7

Cost of sales

As of December 31, 2023, and 2022, the Company had no cost of sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended December 31, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	December 31,		December 31,
	2023		2022
Warrants		239,401		239,401
Options		425,600		425,600
Convertible notes		6,972,559		5,679,287
Total possible dilutive shares		7,637,560		6,344,288

Recent accounting pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements.

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

8

Note 2 - Going Concern

The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the six months ended December 31, 2023, the Company had a net loss of $387,501, and had an accumulated deficit of $12,495,987 as of December 31, 2023.

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company include: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3 – Loan payable due to Eagle - JV partner

July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Membership Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the Membership Agreement.

HIE did not have any operating activities since July 2021. As a result, the Company’s investment balance in HIE as of December 31, 2023 was $0, and the loan balance payable to joint venture partner Eagle totaled $442,251, unchanged since year 2021.

Note 4 - Related Party Transactions

Related party transactions are described in detail in Note 5, Note 6, Note 7, Note 8, and Note 10.

Note 5 – Inventory Financing Payable – related party

On February 19, 2021, Steve Hall, a shareholder of the Company, advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle.

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

9

On October 1, 2021, the Company and Steve Hall entered into a restated and amended promissory note, to consolidate and restate the terms pursuant to which Steve Hall had provided funds to the Company (the “Consolidated Note”). The Consolidated Note consolidated and restated the terms of advances made on February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter. Principal and interest due under the line of credit extended pursuant to the Consolidated Note shall be added to the principal amount due under the Consolidated Note and shall be payable pursuant to the same terms. The line of credit is due and payable on the Due Date unless extended. At the option of holder, the Consolidated Note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

The Consolidated Note’s Due Date was extended to September 30, 2023 and, as of the date of this report, we have not received any notice from Steve Hall indicating his intention to collect or convert the principal and interest under the Consolidated Note.

As of December 31, 2023, and 2022, the accrued interest under the Consolidated Note was $215,342, and $115,342, and the principal balance was $500,000 at the end of both years, respectively.

Note 6 – Line of Credit – related party

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. All principal disbursed under the line of credit will accrue interest, and be payable on the same terms as principal due under the Consolidated Note (see Note 6). The line of credit expired on October 1, 2022. Subsequently, the line of credit has been orally renewed and extended with same terms and a new maturity date of October 1, 2023. Currently, the Company is working with Steve on extension on the Line of Credit.

As of December 31, 2023, and 2022, the outstanding principal of the line of credit totaled $525,000, and $465,000, with accrued interest balances of $154,170, and $51,849, respectively.

Note 7 – Promissory Notes Payable – related party

On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make a follow-on investment in CNTNR USA, Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 9 - Note Receivable.

As of December 31, 2023, the outstanding loan balance was $1,729,750 with accrued interest of $122,291. The Steve Hall Note is past its maturity date. The Company is currently working with Mr. Hall to restructure the note and extend its maturity date.

Note 8 – Accrued Expenses – related party

Between September 2021 to September 2022, the Company had accepted deposits in the total amount of $33,218 from Central National Gottesman, Inc., on a sale of face masks on behalf of Steve Hall, a shareholder of Hawkeye Systems, Inc. As of December 31, 2023, the deposits remain with the Company and have not been sent to Mr. Hall. In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability.

10

Note 9 – Note Receivable

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”). In the Amended CNTNR Note, the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023 that will continue until the Principal Amount is repaid. In exchange for the consulting fee, the Company will provide management consulting and strategic growth services to CNTNR. The balance of the consulting fee is recorded as an accounts receivable. As of December 31, 2023, the accounts receivable has a zero balance.

The Amended CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the Amended CNTNR Note, CNTNR will pay to the Company all outstanding Principal Amount and interest, plus any outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares). The note was informally extened by the parties to January 31, 2024.

Moreover, the Amended CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger with CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued as of December 31, 2023 and will be recorded at fair value as financing income upon issuance at settlement.

The interest is calculated on the total balance of the available loan of $1,000,000 starting on the date of the first transfer on February 28, 2023. As of December 31, 2023, the CNTNR Note and the Amended CNTNR Note have accrued interest of $116,893 with an outstanding principal of $1,548,000. The increase in the principal amount from $1,000,000 to $1,548,000 is due to the Company extending an additional loan of $548,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note. The parties are currently working on amending the Amended CNTNR Note to reflect the increase on the principal amount of such note.

Note 10 – Consulting Agreement - Related Party

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services, including the supervision of the Company’s senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review. The contract period is 12 months with no option for renewal thereafter. The Company has paid Steve Hall a one-time flat service fee of $250,000 on January 31, 2023. Compensation is without recourse and there is no requirement for performance of services during the term of the contract. The contract has expired on December 31, 2023.

On December 1, 2023, Hawkeye entered into a consulting agreement with Christ Mulgrew, the Chief Financial Officer of the Company, to provide consulting services with monthly compensation of $3,500. The contract period is 12 months unless earlier termination. Any extension of the term will be suject to mutual written agreement.

On December 1, 2023, Hawkeye entered into a consulting agreement with Corby Marshall, the Chief Executive Officer of the Company, to provide consulting services with monthly compendsation of $500. The contract period is 12 months unless earlier termination. Any extension of the term will be suject to mutual written agreement.

11

Note 11 - Stockholders’ Equity

Stock Purchase Warrants

Transactions in stock purchase warrants for the three months ended December 31, 2023 are as follows:

	Number of Warrants		Weighted Average Exercise Price
Balance at June 30, 2023		239,401	$	1.04
Expired		-		-
Balance at September 30, 2023		239,401		1.04
Expired		-		-
Balance at December 31, 2023		239,401	$	1.04

The composition of the Company’s warrants outstanding at December 31, 2023 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		35,000		0.33
$	0.50		66,667		0.33
$	1.00		70,867		0.33
$	2.00		66,867		0.33
			239,401		0.33

The intrinsic value of the warrants as of December 31, 2023 was $0.  

Stock Options

Transactions in stock options for the six months ended December 31, 2023 are as follows:

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2023		425,600		1.41		3.41
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2023		425,600		1.41		3.16
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Exercisable, December 31, 2023		425,600	$	1.41		2.90

During the three months ended December 31, 2023, the Company had not granted any stock options. And all stock options were vested at the fiscal year end June 30, 2023.

At December 31, 2023, the intrinsic value of the outstanding options was $0.

12

Note 12 – Stock Reverse Split

Hawkeye filed a form of 8K/A on March 22, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remain the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company had 4,227,222 shares of common stock issued and outstanding on February 8, 2023. In addition, at the effective time of the Reverse Split, all common shares, warrants, options and the related financial information as filed in the Quarterly Report on Form 10-Q of 3^rd quarter of year 2023, in the Annual Report on Form 10-K issued on October 16, 2023, and this Quarterly Report on Form 10-Q of 2nd quarter of year 2024 were retroactively restated to reflect the 1-for-10 reverse stock split for all past and current periods presented.

Note 13 – Commitments and Contingencies

On July 17, 2020, the Company entered into a Membership Agreement with Eagle and Ikon to form HIE. Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. HIE did not have operating activities during the quarter ended December 31, 2023. Detailed discussions are included in Note 3 – Loan payable due to Eagle - JV partner.

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services. Transactions are described in detail in Note 10 - Consulting Agreement - Related Party.

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”) of which the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. Detailed discussions are included in Note 9 - Note Receivable.

Note 14 - Subsequent Events

Management has evaluated subsequent events through the date of these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

13

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion relates to the historical operations and financial statements of Hawkeye Systems, Inc. for the three months ended December 31, 2023.

Forward-Looking Statements

The following Management’s Discussion and Analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this quarterly report. The Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this quarterly report. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risks Factors” in our various filings with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this quarterly report.

The Company is currently looking for investment opportunities into target businesses in diversified industries, such as affordable housing development, and technology applications to mitigate the effects of climate change. While we search for such opportunities, we are currently providing management consulting and strategic growth services to CNTNR USA, Inc (“CNTNR”). Prior to the date of this quarterly report, we have also provided financing to CNTNR.

Financial Condition and Results of Operations

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue our operations.

We expect we will require additional capital to develop our business plan. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

Results of Operations

Three Months Ended December 31, 2023 compared to three months ended December 31, 2022.

We had no operating revenues, and cost of sales, for the three months ended December 31, 2023 and 2022, respectively.

Total operating expenses in the six months ended December 31, 2023 were $300,311 compared to $393,808 for the same period in 2022. The decrease in operating expenses is primarily a result of decreased in professional fees - related party, and management compensation. The Company’s net loss was $387,501 for the six months ended December 31, 2023 compared to $481,388 for the six months ended December 31, 2022. The net loss for this period is primarily a result of operating expenses, and interest expense.

Liquidity and Capital Resources

Our cash balance at December 31, 2023 was $398 compared to $32 at December 31, 2022. We do not believe these cash reserves are sufficient to cover our expenses for our operations for the next 12 months. We will require additional funding for our ongoing operations.

As of our fiscal quarter ended December 31, 2023, we received $279,750, from a promissory note issued by a related party.

In addition, we intend to raise funds through the sale of equity and debt securities. If we cannot raise any additional financing prior to the expiration of the first quarter of 2024, we believe we will be able to obtain loans from management in the future, if necessary, but have no agreement in writing.

We are a smaller reporting company and have accumulated losses to date. Under a limited operations scenario to maintain our corporate existence, we believe we will require additional funds over the next 12 months to complete our regulatory reporting and filings. However, we will require maximum participation through private placements, or alternative financing to implement our business plan.

There are no assurances that we will be able to obtain further funds required for our continued operations. Even if additional financing is available, it may not be available on terms we find favorable. Failure to secure the needed additional financing will have an adverse effect on our ability to remain in business.

14

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through equity offerings, warrant exercises, and related party advances in the near future. We have no guarantees or firm commitments that the related party advances will continue in the near future.

Existing working capital, further advances, together with anticipated capital raises are expected to be adequate to fund our operations over the next twelve months, but there is no guarantee that we will be successful in raising enough capital, or that we will receive the cash flow required to fund our operations. We have no lines of credit with banking institutions or other bank financing arrangements, we do have a line of credit from a related party (see Note 6 to the Financial Statements). Generally, we have financed operations to date through proceeds from convertible loans.

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to continue our operations.

Material Commitments

As of the date of this quarterly report, we have entered into various commitments on loan obligations. For a discussion of the related items, please see Notes 5 to 9 to the Financial Statements.

Purchase of Significant Equipment

We do not intend to purchase any significant equipment during the next twelve months.

Off-Balance Sheet Arrangements

As of the date of this quarterly report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Going Concern

As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $12,495,987 at December 31, 2023 and net loss from operations of $300,311 for the six months ended December 31, 2023.

We do not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of equity securities, proceeds from convertible loans, and related party advances. In addition, the Company is in the development stage and has accumulated losses since inception. These factors raise substantial doubt about our ability to continue as a going concern.

Our ability to continue operations is dependent on the success of Management’s plans and raising of capital through the issuance of equity or debt securities, until such time that funds provided by operations are sufficient to fund working capital requirements.

We will require additional funding to finance our operations and regulatory filing obligations, as well as to identify, negotiate and materialize a business combination with a target business. We believe our current available cash may be insufficient to meet our cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to us, if at all.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

Critical Accounting Policies and Estimates

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 2.

15

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. In our review, we sought to find potential for material weaknesses in our financial controls, which is defined as a deficiency, or combination of deficiencies, in our accounting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatements, whether unintentional errors or fraud. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

Our management, consisting of Corby Marshall as Chief Executive Officer and Christopher Mulgrew as Chief Financial Officer, reviewed and evaluated the effectiveness of the Company’s internal control over disclosure controls and procedures (as such term is defined in Rules 13a-15(3) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) and financial reporting as of December 31, 2023. In making this assessment, our management used the criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), as well as the guidance provided in SEC Release 33-8809. In such an evaluation, Mr. Marshall and Mr. Mulgrew assessed daily interaction, self-assessment and other ongoing monitoring activities as evidence in the evaluation. Furthermore we sought to identify financial reporting risks, identify controls that adequately address financial reporting risks, considered entity level controls, reviewed the role of technology in our controls and reviewed the evidence available to support the assessment.

Based on this evaluation, our management concluded that, as of December 31, 2023, our disclosure controls and our internal controls over financial reporting were not effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed in the reports that we file or submit under the Exchange Act; and were not effective in assuring that information required to be disclosed in the reports we file or submit under the Exchange Act is actually disclosed or filed. Our management concluded that this is due to material weaknesses including (i) the Company having only two officers handling all financial transactions, (ii) lack of appropriate operational controls and consistency in providing our accounting personnel with financial information, (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system, (iv) lack of proper documentation of our assessment and evaluation, and (v) our determination that internal controls were ineffective due to the limited segregation of duties because of the limited management structure.

Changes in Internal Control over Financial Reporting.

There were no changes in our internal control over financial reporting that occurred during the quarter of the year ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

16

PART II - OTHER INFORMATION

Item 1 - Legal Proceedings

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, we are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this quarterly report, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our properties that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition.

Item 1A - Risk Factors

Not required for Smaller Reporting Companies.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

No disclosure required.

Item 3 - Defaults Upon Senior Securities

No disclosure required.

Item 4 - Mine Safety Disclosure

No disclosure required.

Item 5 - Other Information

No disclosure required.

17

Item 6 - Exhibits

Exhibits:

Exhibit	Description
31.1*	Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934
31.2*	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934
32.1*	Certification of Chief Executive Officer pursuant to Section 1350
32.2**	Certification of Chief Financial Officer pursuant to Section 1350
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*	Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

* Filed herewith.

** Furnished herewith.

18

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hawkeye Systems, Inc.
Date: February 8, 2024	By:	/s/ Corby Marshall
		Corby Marshall, Chief Executive Officer
		Principal Executive Officer
Date: February 8, 2024	By:	/s/ Christopher Mulgrew
		Christopher Mulgrew, Chief Financial Officer
		Principal Financial Officer

19

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Corby Marshall, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Hawkeye Systems, Inc. (the “Registrant”);
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2024	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Christopher Mulgrew, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Hawkeye Systems, Inc. (the “Registrant”);
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2024	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Corby Marshall, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Date: February 8, 2024	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Mulgrew, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

Date: February 8, 2024	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

XML

Cover - shares	6 Months Ended
	Dec. 31, 2023	Feb. 08, 2024
Cover [Abstract]
Entity Registrant Name	HAWKEYE SYSTEMS, INC.
Entity Central Index Key	0001750777
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		5,552,222
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-180954
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	83-0799093
Entity Address Address Line 1	6605 Abercorn
Entity Address Address Line 2	Suite 204
Entity Address City Or Town	Savannah
Entity Address State Or Province	GA
Entity Address Postal Zip Code	31405
City Area Code	912
Local Phone Number	253-0375
Entity Interactive Data Current	Yes

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current assets:
Cash	$ 398	$ 143,861
Prepaid expenses	10,000	2,370
Interest receivable	116,893	40,438
Loan receivable	1,548,000	800,000
Total current assets	1,675,291	986,669
Total assets	1,675,291	986,669
Current liabilities:
Accounts payable and accrued liabilities - related party	383,718	730,454
Accounts payable and accrued liabilities	15,580	13,644
Convertible note payable, net of discount - related party	500,000	500,000
Accrued interest - related party	491,802	298,158
Line of credit - related party	525,000	525,000
Promissory note payable - related party	1,729,750	1,000,000
Total current liabilities	3,645,850	3,067,256
Long-term liabilities:
Loan payable due to Eagle - JV partner	442,251	442,251
Total liabilities	4,088,101	3,509,507
Commitments and contingencies (Note -13)	0	0
Stockholders' deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 5,552,222 and 5,552,222 shares issued and outstanding, respectively	555	555
Common shares to be Issued	497,528	0
Additional paid-in capital	9,585,094	9,585,094
Accumulated deficit	(12,495,987)	(12,108,487)
Total stockholders' deficit	(2,412,810)	(2,522,838)
Total liabilities and stockholders' deficit	$ 1,675,291	$ 986,669

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2023	Jun. 30, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	5,552,222	5,552,222
Common stock, shares outstanding	5,552,222	5,552,222

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
General and administrative	$ 16,170	$ 21,212	$ 37,765	$ 48,966
Management compensation	78,167	111,250	189,417	222,551
Professional fees	37,133	86,865	73,129	107,291
Professional fees - related party	0	0	0	15,000
Total operating expenses	131,470	219,327	300,311	393,808
Loss from operations	(131,470)	(219,327)	(300,311)	(393,808)
Other income (expense), net:
Other income	15,000	0	30,000	0
Interest income	44,450	0	76,454	0
Interest expense - related party	(101,234)	(46,965)	(193,644)	(87,580)
Total other income (expense), net	(41,784)	(46,965)	(87,190)	(87,580)
Net loss before income taxes provision	(173,254)	(266,292)	(387,501)	(481,388)
Provision for income tax	0	0	0	0
Net loss	$ (173,254)	$ (266,292)	$ (387,501)	$ (481,388)
Net loss per common share - basic and diluted	$ (0.03)	$ (0.10)	$ (0.07)	$ (0.10)
Weighted average common shares outstanding - basic and diluted	5,552,222	4,227,082	5,552,222	3,982,582

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock to be issued	Retained Earnings (Accumulated Deficit)
Balance, shares at Jun. 30, 2022		2,560,416
Balance, amount at Jun. 30, 2022	$ (2,103,529)	$ 256	$ 8,778,391		$ (10,882,176)
Common stock issued for common stock payable, shares		1,666,667
Common stock issued for common stock payable, amount	594,344	$ 167	594,177		0
Stock based compensation - options	5,159	$ 0	5,159		0
Net loss	(215,096)				(215,096)
Balance, shares at Sep. 30, 2022		4,227,083
Balance, Amount at Sep. 30, 2022	(1,719,122)	$ 423	9,377,727		(11,097,272)
Balance, shares at Jun. 30, 2022		2,560,416
Balance, amount at Jun. 30, 2022	(2,103,529)	$ 256	8,778,391		(10,882,176)
Stock based compensation - options	5,159
Net loss	(481,388)
Balance, shares at Dec. 31, 2022		4,227,083
Balance, Amount at Dec. 31, 2022	(1,985,414)	$ 423	9,377,727		(11,363,564)
Balance, shares at Sep. 30, 2022		4,227,083
Balance, amount at Sep. 30, 2022	(1,719,122)	$ 423	9,377,727		(11,097,272)
Net loss	(266,292)	$ 0	0		(266,292)
Balance, shares at Dec. 31, 2022		4,227,083
Balance, Amount at Dec. 31, 2022	(1,985,414)	$ 423	9,377,727		(11,363,564)
Balance, shares at Jun. 30, 2023		5,552,223
Balance, amount at Jun. 30, 2023	(2,522,838)	$ 555	9,585,094	$ 0	(12,108,487)
Net loss	(214,247)			0	(214,247)
Balance, shares at Sep. 30, 2023		5,552,223
Balance, Amount at Sep. 30, 2023	(2,737,085)	$ 555	9,585,094	0	(12,322,734)
Balance, shares at Jun. 30, 2023		5,552,223
Balance, amount at Jun. 30, 2023	(2,522,838)	$ 555	9,585,094	0	(12,108,487)
Stock based compensation - options	0
Net loss	(387,501)
Balance, shares at Dec. 31, 2023		5,552,223
Balance, Amount at Dec. 31, 2023	(2,412,810)	$ 555	9,585,094	497,528	(12,495,987)
Balance, shares at Sep. 30, 2023		5,552,223
Balance, amount at Sep. 30, 2023	(2,737,085)	$ 555	9,585,094	0	(12,322,734)
Stock based compensation - options	497,528	0	0	497,528	0
Net loss	(173,254)	$ 0	0	0	(173,254)
Balance, shares at Dec. 31, 2023		5,552,223
Balance, Amount at Dec. 31, 2023	$ (2,412,810)	$ 555	$ 9,585,094	$ 497,528	$ (12,495,987)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (387,501)	$ (481,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation - options and warrant	0	5,159
Common stock issued for settlement of compensation	497,528	0
Change in operating assets and liabilities:
Prepaid expense	(7,631)	(8,147)
Interest receivable	(76,455)	0
Accounts payable and accrued liabilities- related party	(346,735)	284,083
Accounts payable and accrued liabilities	1,936	0
Accrued interest - related party	193,644	0
Net cash used in operating activities	(125,213)	(200,293)
Cash flows from investing activities:
Note receivable from CNTNR	(748,000)	0
Net cash used in investing activities	(748,000)	0
Cash flows from financing activities:
Net proceeds from Promissory note - related party	729,750	0
Net proceeds from line of credit	0	200,000
Net cash provided by financing activities	729,750	200,000
Net change in cash	(143,463)	(293)
Cash beginning of period	143,861	325
Cash end of period	398	32
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Common stock issued exchanged for common stock payable - related party	0	594,344
Common stock to be issued for settlement of service	$ 497,528	$ 0

XML

Summary of Significant Accounting Policies

6 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 1 - Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources.

Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

As of December 31, 2023, and 2022, the Company had no revenue.

Cost of sales

As of December 31, 2023, and 2022, the Company had no cost of sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended December 31, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	December 31,		December 31,
	2023		2022
Warrants		239,401		239,401
Options		425,600		425,600
Convertible notes		6,972,559		5,679,287
Total possible dilutive shares		7,637,560		6,344,288

Recent accounting pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements.

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

XML

Going Concern

6 Months Ended

Dec. 31, 2023

Going Concern

Going Concern

Note 2 - Going Concern

The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the six months ended December 31, 2023, the Company had a net loss of $387,501, and had an accumulated deficit of $12,495,987 as of December 31, 2023.

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company include: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Loan payable due to Eagle JV partner

6 Months Ended

Dec. 31, 2023

Loan payable due to Eagle JV partner

Loan payable due to Eagle - JV partner

Note 3 – Loan payable due to Eagle - JV partner

July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Membership Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the Membership Agreement.

HIE did not have any operating activities since July 2021. As a result, the Company’s investment balance in HIE as of December 31, 2023 was $0, and the loan balance payable to joint venture partner Eagle totaled $442,251, unchanged since year 2021.

XML

Related Party Transactions

6 Months Ended

Dec. 31, 2023

Related Party Transactions

Related Party Transactions

Note 4 - Related Party Transactions

Related party transactions are described in detail in Note 5, Note 6, Note 7, Note 8, and Note 10.

XML

Inventory Financing Payable related party

6 Months Ended

Dec. 31, 2023

Inventory Financing Payable related party

Inventory Financing Payable - related party

Note 5 – Inventory Financing Payable – related party

On February 19, 2021, Steve Hall, a shareholder of the Company, advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle.

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

On October 1, 2021, the Company and Steve Hall entered into a restated and amended promissory note, to consolidate and restate the terms pursuant to which Steve Hall had provided funds to the Company (the “Consolidated Note”). The Consolidated Note consolidated and restated the terms of advances made on February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter. Principal and interest due under the line of credit extended pursuant to the Consolidated Note shall be added to the principal amount due under the Consolidated Note and shall be payable pursuant to the same terms. The line of credit is due and payable on the Due Date unless extended. At the option of holder, the Consolidated Note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

The Consolidated Note’s Due Date was extended to September 30, 2023 and, as of the date of this report, we have not received any notice from Steve Hall indicating his intention to collect or convert the principal and interest under the Consolidated Note.

As of December 31, 2023, and 2022, the accrued interest under the Consolidated Note was $215,342, and $115,342, and the principal balance was $500,000 at the end of both years, respectively.

XML

Line of Credit related party

6 Months Ended

Dec. 31, 2023

Line of Credit related party

Line of Credit - related party

Note 6 – Line of Credit – related party

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. All principal disbursed under the line of credit will accrue interest, and be payable on the same terms as principal due under the Consolidated Note (see Note 6). The line of credit expired on October 1, 2022. Subsequently, the line of credit has been orally renewed and extended with same terms and a new maturity date of October 1, 2023. Currently, the Company is working with Steve on extension on the Line of Credit.

As of December 31, 2023, and 2022, the outstanding principal of the line of credit totaled $525,000, and $465,000, with accrued interest balances of $154,170, and $51,849, respectively.

XML

Promissory notes payable related party

6 Months Ended

Dec. 31, 2023

Promissory notes payable related party

Promissory notes payable - related party

Note 7 – Promissory Notes Payable – related party

On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make a follow-on investment in CNTNR USA, Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 9 - Note Receivable.

As of December 31, 2023, the outstanding loan balance was $1,729,750 with accrued interest of $122,291. The Steve Hall Note is past its maturity date. The Company is currently working with Mr. Hall to restructure the note and extend its maturity date.

XML

Accrued expenses related party

6 Months Ended

Dec. 31, 2023

Accrued expenses related party

Accrued expenses - related party

Note 8 – Accrued Expenses – related party

Between September 2021 to September 2022, the Company had accepted deposits in the total amount of $33,218 from Central National Gottesman, Inc., on a sale of face masks on behalf of Steve Hall, a shareholder of Hawkeye Systems, Inc. As of December 31, 2023, the deposits remain with the Company and have not been sent to Mr. Hall. In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability.

XML

Note receivable

6 Months Ended

Dec. 31, 2023

Note receivable

Note receivable

Note 9 – Note Receivable

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”). In the Amended CNTNR Note, the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023 that will continue until the Principal Amount is repaid. In exchange for the consulting fee, the Company will provide management consulting and strategic growth services to CNTNR. The balance of the consulting fee is recorded as an accounts receivable. As of December 31, 2023, the accounts receivable has a zero balance.

The Amended CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the Amended CNTNR Note, CNTNR will pay to the Company all outstanding Principal Amount and interest, plus any outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares). The note was informally extened by the parties to January 31, 2024.

Moreover, the Amended CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger with CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued as of December 31, 2023 and will be recorded at fair value as financing income upon issuance at settlement.

The interest is calculated on the total balance of the available loan of $1,000,000 starting on the date of the first transfer on February 28, 2023. As of December 31, 2023, the CNTNR Note and the Amended CNTNR Note have accrued interest of $116,893 with an outstanding principal of $1,548,000. The increase in the principal amount from $1,000,000 to $1,548,000 is due to the Company extending an additional loan of $548,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note. The parties are currently working on amending the Amended CNTNR Note to reflect the increase on the principal amount of such note.

XML

Consulting Agreement Related Party

6 Months Ended

Dec. 31, 2023

Consulting Agreement Related Party

Consulting Agreement - Related Party

Note 10 – Consulting Agreement - Related Party

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services, including the supervision of the Company’s senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review. The contract period is 12 months with no option for renewal thereafter. The Company has paid Steve Hall a one-time flat service fee of $250,000 on January 31, 2023. Compensation is without recourse and there is no requirement for performance of services during the term of the contract. The contract has expired on December 31, 2023.

On December 1, 2023, Hawkeye entered into a consulting agreement with Christ Mulgrew, the Chief Financial Officer of the Company, to provide consulting services with monthly compensation of $3,500. The contract period is 12 months unless earlier termination. Any extension of the term will be suject to mutual written agreement.

On December 1, 2023, Hawkeye entered into a consulting agreement with Corby Marshall, the Chief Executive Officer of the Company, to provide consulting services with monthly compendsation of $500. The contract period is 12 months unless earlier termination. Any extension of the term will be suject to mutual written agreement.

XML

Stockholders Equity

6 Months Ended

Dec. 31, 2023

Stockholders Equity

Stockholders' Equity

Note 11 - Stockholders’ Equity

Stock Purchase Warrants

Transactions in stock purchase warrants for the three months ended December 31, 2023 are as follows:

	Number of Warrants		Weighted Average Exercise Price
Balance at June 30, 2023		239,401	$	1.04
Expired		-		-
Balance at September 30, 2023		239,401		1.04
Expired		-		-
Balance at December 31, 2023		239,401	$	1.04

The composition of the Company’s warrants outstanding at December 31, 2023 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		35,000		0.33
$	0.50		66,667		0.33
$	1.00		70,867		0.33
$	2.00		66,867		0.33
			239,401		0.33

The intrinsic value of the warrants as of December 31, 2023 was $0.  

Stock Options

Transactions in stock options for the six months ended December 31, 2023 are as follows:

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2023		425,600		1.41		3.41
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2023		425,600		1.41		3.16
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Exercisable, December 31, 2023		425,600	$	1.41		2.90

During the three months ended December 31, 2023, the Company had not granted any stock options. And all stock options were vested at the fiscal year end June 30, 2023.

At December 31, 2023, the intrinsic value of the outstanding options was $0.

XML

Stock Reverse Split

6 Months Ended

Dec. 31, 2023

Stock Reverse Split

Stock Reverse Split

Note 12 – Stock Reverse Split

Hawkeye filed a form of 8K/A on March 22, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remain the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company had 4,227,222 shares of common stock issued and outstanding on February 8, 2023. In addition, at the effective time of the Reverse Split, all common shares, warrants, options and the related financial information as filed in the Quarterly Report on Form 10-Q of 3^rd quarter of year 2023, in the Annual Report on Form 10-K issued on October 16, 2023, and this Quarterly Report on Form 10-Q of 2nd quarter of year 2024 were retroactively restated to reflect the 1-for-10 reverse stock split for all past and current periods presented.

XML

Commitments and Contingencies

6 Months Ended

Dec. 31, 2023

Commitments and Contingencies

Commitments and Contingencies

Note 13 – Commitments and Contingencies

On July 17, 2020, the Company entered into a Membership Agreement with Eagle and Ikon to form HIE. Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. HIE did not have operating activities during the quarter ended December 31, 2023. Detailed discussions are included in Note 3 – Loan payable due to Eagle - JV partner.

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services. Transactions are described in detail in Note 10 - Consulting Agreement - Related Party.

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”) of which the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. Detailed discussions are included in Note 9 - Note Receivable.

XML

Subsequent Events

6 Months Ended

Dec. 31, 2023

Subsequent Events

Subsequent Events

Note 14 - Subsequent Events

Management has evaluated subsequent events through the date of these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies

Business Overview

Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources.

Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

As of December 31, 2023, and 2022, the Company had no revenue.

Cost of sales

As of December 31, 2023, and 2022, the Company had no cost of sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended December 31, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	December 31,		December 31,
	2023		2022
Warrants		239,401		239,401
Options		425,600		425,600
Convertible notes		6,972,559		5,679,287
Total possible dilutive shares		7,637,560		6,344,288

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements.

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies

Schedule Of potentially dilutive common stock

	December 31,		December 31,
	2023		2022
Warrants		239,401		239,401
Options		425,600		425,600
Convertible notes		6,972,559		5,679,287
Total possible dilutive shares		7,637,560		6,344,288

XML

Stockholders Equity (Tables)

6 Months Ended

Dec. 31, 2023

Stockholders Equity

Schedule of transactions in stock purchase warrants

	Number of Warrants		Weighted Average Exercise Price
Balance at June 30, 2023		239,401	$	1.04
Expired		-		-
Balance at September 30, 2023		239,401		1.04
Expired		-		-
Balance at December 31, 2023		239,401	$	1.04

Schedule of warrants outstanding

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		35,000		0.33
$	0.50		66,667		0.33
$	1.00		70,867		0.33
$	2.00		66,867		0.33
			239,401		0.33

Schedule Of Transactions in stock options

					Weighted average
	Number of		Weighted average		remaining life
	options		exercise price		(in years)
Outstanding, June 30, 2023		425,600		1.41		3.41
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2023		425,600		1.41		3.16
Granted		-		-		-
Cancelled		-		-		-
Exercised		-		-		-
Exercisable, December 31, 2023		425,600	$	1.41		2.90

XML

Summary of Significant Accounting Policies (Details) - shares	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Convertible Note [Member]
Total possible dilutive shares	6,972,559	5,679,287
Options [Member]
Total possible dilutive shares	425,600	425,600
Total Possible Dilutive Shares [Member]
Total possible dilutive shares	7,637,560	6,344,288
Warrant [Member]
Total possible dilutive shares	239,401	239,401

XML

Going Concern (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Going Concern
Net loss	$ (173,254)	$ (214,247)	$ (266,292)	$ (215,096)	$ (387,501)	$ (481,388)
Accumulated deficit	$ (12,495,987)				$ (12,495,987)		$ (12,108,487)

XML

Loan payable due to Eagle JV partner (Details Narrative) - USD ($)	1 Months Ended
	Jul. 17, 2020	Dec. 31, 2023
Description of membership agreement	the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle
Loan Payable		$ 442,251
Profit sharing for each member, percentage	33.30%
HIE [Member]
Investment in HIE		$ 0
Percentage of contingent liablility to repay origination loan and additional contribution	33.30%

XML

Inventory Financing Payable related party (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Oct. 01, 2021	Feb. 19, 2021	Jun. 30, 2021	Dec. 31, 2023	Feb. 27, 2023	Dec. 31, 2022
Inventory Financing Payable related party
Advances from related party		$ 1,000,000
Related party transaction description		The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle
Repayment to related party			$ 500,000
Description Of Business	February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter
Common stock shares conversion price	$ 0.02
Accrued interest				$ 215,342		$ 115,342
Principal amount				$ 500,000	$ 1,000,000

XML

Line of Credit related party (Details Narrative) - USD ($)	Oct. 01, 2021	Dec. 31, 2023	Dec. 31, 2022
Outstanding line of credit		$ 525,000	$ 465,000
Accrued interest payable		$ 154,170	$ 51,849
On October 1, 2021 | Line of credit related party description | Steve Hall [Member]
Line of credit related party description	agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter
Expiry date of line of credit	October 1, 2023

XML

Promissory notes payable related party (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Mar. 29, 2023	Dec. 31, 2023	Jun. 30, 2023
Promissory notes payable related party
Promissory note payable - related party	$ 1,000,000	$ 1,729,750	$ 1,000,000
Annual interest rate of loan	12.00%
Note repayment terms, description		the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants
Accrued interest related party		$ 122,291

XML

Accrued expenses related party (Details Narrative)	13 Months Ended
	Sep. 30, 2022 USD ($)
Hawkeye Systems, Inc [Member]
Accepted deposits	$ 33,218

XML

Note receivable (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended
	Feb. 28, 2023	Feb. 27, 2023	Dec. 31, 2023	Dec. 31, 2022
Advanced payment		$ 200,000
Commitment fees rate		5.00%
Principal amount		$ 1,000,000	$ 500,000
Accrued interest			154,170	$ 51,849
CNTNR [Member]
Advanced payment		$ 200,000
Commitment fees rate		5.00%
Monthly consulting fee			5,000
Annual interest rate		12.00%
Maturity date		Sep. 30, 2023
Principal amount			6,170,879
Discripiton of warrants discount		The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023
Accrued interest			$ 116,893
Interest amount	$ 1,000,000
Description of Extending Additional Loan			The increase in the principal amount from $1,000,000 to $1,548,000 is due to the Company extending an additional loan of $548,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note

XML

Consulting Agreement - Related Party (Details Narrative) - USD ($)		1 Months Ended
	Dec. 01, 2023	Jan. 31, 2023
Consulting Agreement [Member]
Service fee		$ 250,000
Contract period	12 months
Consulting Agreement With Christ [Member]
Compensation amount	$ 3,500
Contract period	12 months
Consulting Agreement With Corby Marshall [Member]
Compensation amount	$ 500
Contract period	12 months

XML

Stockholders Equity (Details) - Stock Purchase Warrants [Member] - USD ($)	3 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Warrant shares, Beginning	239,401	239,401
Warrant shares, Expired	$ 0	$ 0
Warrant shares, Ending	239,401	239,401
Weighted average exercise price, Beginning	$ 1.04	$ 1.04
Weighted average exercise price, Expired	0	0
Weighted average exercise price, Ending	$ 1.04	$ 1.04

XML

Stockholders Equity (Details 1)	6 Months Ended
	Dec. 31, 2023 $ / shares shares
Warrants outsanding 1 [Member]
Exercise Price | $ / shares	$ 0.30
Number of Warrants	35,000
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding 2 [Member]
Exercise Price | $ / shares	$ 0.50
Number of Warrants	66,667
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding 3 [Member]
Exercise Price | $ / shares	$ 1.00
Number of Warrants	70,867
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding 4 [Member]
Exercise Price | $ / shares	$ 2.00
Number of Warrants	66,867
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding [Member]
Number of Warrants	239,401
Weighted Average Remaining Life (in years)	10 days

XML

Stockholders Equity (Details 2) - Stock Options [Member] - $ / shares	3 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Number of options, beginning balance	425,600	425,600
Number of options, ending balance	425,600	425,600
Number of options, Exercisable	425,600
Weighted Average Exercise Price, beginning balance	$ 1.41	$ 1.41
Weighted Average Exercise Price, ending balance	1.41	$ 1.41
Weighted Average Exercise Price, Exercisable	$ 1.41
Weighted average remaining life, beginning	3 months 4 days	3 months 12 days
Weighted average remaining life, ending	2 years 10 months 24 days	3 years 1 month 28 days
Weighted average remaining life, exercisable	2 months 27 days

XML

Stockholders Equity (Details Narrative)	Dec. 31, 2023 USD ($)
Warrant [Member]
Intrinsic value of the outstanding options	$ 0
Stock Options [Member]
Intrinsic value of the outstanding options	$ 0

XML

Stock Reverse Split (Details Narrative) - $ / shares	6 Months Ended
	Dec. 31, 2023	Jun. 30, 2023
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	5,552,222	5,552,222
Stock Reverse Split [Member]
Common stock par value	$ 0.0001
Common stock, shares outstanding	4,227,222
Description of stock reverse split	The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding

XML

Commitments and Contingencies (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Feb. 27, 2023	Dec. 31, 2023
Commitments and Contingencies
Origination Loan		33.30%
Principal amount	$ 1,000,000	$ 500,000
Advanced payment	$ 200,000
Commitment fees rate	5.00%